Table 1: Correlation of clinical parameters with cyclin D1
|
Parameters |
Negative |
Low Expressers |
High Expressers |
P-values |
|
Cyclin D1 |
Cyclin D1 |
Cyclin D1 |
||
|
Age of patients (years) |
||||
|
20-29 |
10 (15.15%) |
0 |
2 (3%) |
0.698 |
|
30-39 |
9 (13.6%) |
0 |
4(6%) |
|
|
40-49 |
6(9%) |
2(3%) |
9(13.6%) |
|
|
50-59 |
4(6%) |
1(1.51%) |
6(9%) |
|
|
60-69 |
5(7.5%) |
4(6%) |
1(1.51%) |
|
|
≥ 70 |
0 |
0 |
3(4.5%) |
|
|
Sex |
||||
|
Male |
27 (40.9%) |
3(4.5%) |
19(28.7%) |
2.146 |
|
Female |
6(9%) |
1(1.5%) |
10(15.5%) |
|
|
WHO Grade |
||||
|
I |
4 (6.06%) |
0 |
0 |
< 0.0001 |
|
II |
14 (21.21%) |
0 |
1(1.5%) |
|
|
III |
7 (10.6%) |
2(3%) |
4(6%) |
|
|
IV |
8(12.1%) |
2(3%) |
24(36.3%) |
|
|
IDH |
||||
|
Wild type |
11 (16.6%) |
3(4.5%) |
28(42.4%) |
< 0.0001 |
|
Mutant |
22(33.3%) |
1(1.5%) |
1(1.5%) |
|